Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts. - Wikidata - awgldk - TriplyDB

Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

http://www.wikidata.org/entity/Q37438010

about

Clinical Relevance of Biomarkers of Oxidative Stress Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids Isoketals form cytotoxic phosphatidylethanolamine adducts in cells A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.New covalent modifications of phosphatidylethanolamine by alkanals: mass spectrometry based structural characterization and biological effects.Mass spectrometry detection of isolevuglandin adduction to specific protein residues.Phosphatidylethanolamines modified by γ-ketoaldehyde (γKA) induce endoplasmic reticulum stress and endothelial activation.Isolevuglandin adducts in disease Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation.Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1 Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.Photo-damage, photo-protection and age-related macular degeneration.Efficient Quantitative Analysis of Carboxyalkylpyrrole Ethanolamine Phospholipids: Elevated Levels in Sickle Cell Disease Blood.Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs).Molecular Structures of Isolevuglandin-Protein Cross-Links.Bioactive 4-Oxoheptanedioic Monoamide Derivatives of Proteins and Ethanolaminephospholipids: Products of Docosahexaenoate Oxidation.

P2860

Q26785512-0A4F2CDA-09C5-4229-8A8B-8D3B9B8BFE16 Q28389004-FCAEC057-D5A5-4B98-A7A6-C6229782738A Q33784657-AA9069F6-853C-4997-8EE6-28B68AE58ECA Q34069221-24FCD05F-F22F-43F8-9225-0A691C8F4105 Q34299750-4815716C-CB12-4B28-98AF-0B9C1A68C5CA Q34392320-CA4A3811-7784-49C1-813D-960AAFFF641F Q34561546-13A4053E-5715-4E91-BF8C-B4D911CCF1F3 Q34979101-771857CA-EBCC-49D4-A895-FD22A694B58C Q35794678-7AFF4533-D5D6-46A3-998B-7BB4A001F6AA Q35797182-79D1B63B-F23E-47CF-A934-2B7702FD9864 Q36290443-A908095B-1E5B-4A90-945B-B8B3B055346C Q36754829-70E4CA44-F316-4958-9848-225E5BC85D5D Q37222710-9410E4D0-21BF-4FE3-81FA-EFA907147540 Q37226073-F0135D23-4DD2-4710-B8C1-E4E5E5E1D9DA Q38551646-73B076A3-161A-417A-8370-12F248E84DDA Q40996005-7BA2157A-34FE-4ED4-BA9C-E52CFA9229FC Q42122346-30E6D65D-F85B-4A89-8ABD-412FDB98393C Q42214486-B0B9BBE4-1BEF-40E2-8EDB-40D2FEDDC2FA Q42316579-D87C9736-FD77-4AB3-A932-C86FEA83E702

P2860

Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

http://www.wikidata.org/entity/Q37438010

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@en

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@nl

type

label

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@en

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@nl

prefLabel

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@en

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@nl

P1433

Q37438010-C29F2680-1A1D-43BE-8612-E26445ABB095

P1476

Q37438010-E4B6D89D-FC47-4A7F-81AA-503D61528FD2

P2093

Q37438010-055C1AD7-7B77-4D89-B4CA-0C1B8D828447

Q37438010-09DB0BC1-C8FF-4C04-B334-A6D95C53304A

Q37438010-0A3E040D-A2F5-4310-AEEB-5ECE7DD9AA14

Q37438010-D2724A38-6B66-4D06-8338-16C9718B41EE

Q37438010-D66E9F76-B872-4016-8D68-BA9B10F4E5B4

Q37438010-E8769494-99DB-485C-A9B8-60DE6D23C1EC

Q37438010-F16537EE-2B23-40AD-9048-EECF99C87C37

Q37438010-F91C1E55-0313-4FAD-A0D1-36557AE52FF9

P2860

Q37438010-02E390EF-8571-49D2-99A4-F9A36E32DA5D

Q37438010-0D6DFEAF-4E9B-4EAA-8A5B-8AB10841E9FC

Q37438010-105834C5-A11D-4919-B682-6B944BEF87A6

Q37438010-1A734200-5A0D-42F2-8DEB-FE1B1D740DFE

Q37438010-1AE1427C-E77F-440C-95B6-35403B2445CE

Q37438010-1BE08FC1-3098-4527-8368-B8E93F90EBE3

Q37438010-3B7AD516-86D0-4F66-A3F6-C2B4A1382DB8

Q37438010-465207A5-C867-4461-84B8-84C693DC8751

Q37438010-4E7922DE-87A5-449A-BD45-B6F921026957

Q37438010-5AFC1D3F-9CC0-4F02-BBBF-CD1D3F7FA4F7

P304

Q37438010-2900DF36-E54F-45CD-9A29-3BC3767F3C9A

P31

Q37438010-DF79006E-3E25-44CF-B0F2-5FEE888CBB85

P356

Q37438010-299F9B99-5727-4CB2-8C0E-A4ADC25D4352

P433

Q37438010-AE004788-02B3-4822-B3F1-08214CE25FD1

P478

Q37438010-1065C5C7-6713-4B86-B88D-EA165862BB84

P577

Q37438010-E32783F3-D5B6-42F9-A35F-CA847FDA15F5

P698

Q37438010-F2E98ABD-3E19-444C-866A-2E68C82CA53C

P932

Q37438010-1EAEBD07-ADF0-47A0-B1D1-C6E5482DE41E

P356

J.FREERADBIOMED.2009.09.003

P1433

Free Radical Biology and Medicine

P1476

Isolevuglandins covalently mod ...... ysis of hydroxylactam adducts.

@en

P2093

James M Laird

http://www.w3.org/2001/XMLSchema#string

John W Crabb

http://www.w3.org/2001/XMLSchema#string

Laura E Nagy

http://www.w3.org/2001/XMLSchema#string

Liang Lu

http://www.w3.org/2001/XMLSchema#string

Robert G Salomon

http://www.w3.org/2001/XMLSchema#string

Rong Zhou

http://www.w3.org/2001/XMLSchema#string

Sanjoy Roychowdhury

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

P2860

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

A simple method for the isolation and purification of total lipides from animal tissues

Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

Systemic complement activation in age-related macular degeneration

Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2

Characterization of acrolein-glycerophosphoethanolamine lipid adducts using electrospray mass spectrometry

New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

P304

1539-1552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FREERADBIOMED.2009.09.003

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19751823

http://www.w3.org/2001/XMLSchema#string

P932

2783230

http://www.w3.org/2001/XMLSchema#string